Axcella Health Stock Price, News & Analysis (NASDAQ:AXLA)

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

Axcella Health Inc (NASDAQ:AXLA) issued its quarterly earnings results on Monday, August, 12th. The company reported ($0.95) EPS for the quarter, missing analysts' consensus estimates of ($0.65) by $0.31. View Axcella Health's Earnings History.

Axcella Health is scheduled to release their next quarterly earnings announcement on Monday, November 11th 2019. View Earnings Estimates for Axcella Health.

4 brokers have issued 1-year target prices for Axcella Health's stock. Their forecasts range from $20.00 to $25.00. On average, they anticipate Axcella Health's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 327.2% from the stock's current price. View Analyst Price Targets for Axcella Health.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axcella Health.

Media coverage about AXLA stock has been trending somewhat negative on Saturday, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Axcella Health earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Axcella Health.

Axcella Health saw a drop in short interest in the month of September. As of September 30th, there was short interest totalling 40,000 shares, a drop of 7.6% from the August 30th total of 43,300 shares. Based on an average daily trading volume, of 12,300 shares, the short-interest ratio is currently 3.3 days. Approximately 0.5% of the company's shares are short sold. View Axcella Health's Current Options Chain.

Some companies that are related to Axcella Health include Replimune Group (REPL), DBV TECHNOLOGIE/S (DBVT), Adverum Biotechnologies (ADVM), Cellectis (CLLS), Translate Bio (TBIO), Tcr2 Therapeutics (TCRR), Prevail Therapeutics (PRVL), Agenus (AGEN), Avrobio (AVRO), Harpoon Therapeutics (HARP), Precision BioSciences (DTIL), CASI Pharmaceuticals (CASI), Cellular Biomedicine Group (CBMG), Scholar Rock (SRRK) and Gritstone Oncology (GRTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Triton International (TRTN), Main Street Capital (MAIN), Achillion Pharmaceuticals (ACHN), Adobe (ADBE), Blackline (BL), Coda Octopus Group (CODA), Exelixis (EXEL), Stamps.com (STMP), Xilinx (XLNX) and Delek US (DK).

(AXLA) raised $76 million in an initial public offering on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

Axcella Health's lock-up period expires on Tuesday, November 5th. Axcella Health had issued 3,571,428 shares in its initial public offering on May 9th. The total size of the offering was $71,428,560 based on an initial share price of $20.00. After the expiration of Axcella Health's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AXLA stock can currently be purchased for approximately $5.15.

Axcella Health has a market capitalization of $118.86 million. View Additional Information About Axcella Health.

The official website for Axcella Health is http://www.axcellahealth.com/.

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.